Does dark chocolate have a role in the prevention and management of hypertension?: Commentary on the evidence

Hypertension

Volumn 55, Issue 6, 2010, Pages 1289-1295

  Egan, Brent M ^a   Lakenx, Marilyn A ^b   Donovan, Jennifer L ^a   Woolson, Robert F ^a,c,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Chocolate; Cocoa; Hypertension; Prehypertension; Prevention

Indexed keywords

ARTERIAL PRESSURE; BIOLOGICAL ACTIVITY; BLOOD PRESSURE MEASUREMENT; CACAO; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; ETHNIC GROUP; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; NONHUMAN; PEER REVIEW; PLACEBO EFFECT; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; SHORT SURVEY; SOCIAL CLASS; SOCIAL ENVIRONMENT; TREATMENT DURATION;

BLOOD PRESSURE DETERMINATION; CACAO; CANDY; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LIFE STYLE; MALE; PRIMARY PREVENTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77952953215     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.151522     Document Type: Short Survey

References (55)

1. Ostchega Y, Yoon SS, Highes J, Louis T. Hypertension awareness, treatment, and control: continued disparities in adults-United States, 2005-2006. NCHS Data Brief. 2008;(3):1-8.
2. US Census Bureau. USA QuickFacts from the US Census Bureau. Available at: http://quickfacts.census.gov/qfd/states/00000.html. Accessed January 7, 2010.
3. Kannel WB. Hypertension: reflection on risks and prognostication. Med Clin North Am. 2009;93:541-548.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Izzo JUL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
5. Egan BM, Julius S. Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008;10:359-366.
6. Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandez J, Riehle JE, Nesbitt S, Julius S. Metabolic syndrome and insulin resistance: Contrasting views in patients with high normal blood pressure. Am J Hypertens. 2005;18:3-12.
7. Palombo C, Kozakova M, Magagna A, Bigalli G, Morizzo C, Ghiadoni L, Virdis A, Emdin M, Taddei S, L'Abbate A, Silvetti A. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens. 2000;18:453-459.
8. Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JS, Hartiala JJ, Raitakari OT. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension. 2000;36:929-933.
9. Mellen PB, Gao SK, Vitolins MZ, Goff DC. Deteriorating dietary habits among adults with hypertension. Arch Int Med. 2008;168:308-314.
10. Ford ES, Zhao G, Li C, Pearson WS, Mokdad AH. Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens. 2008;21:1124-1128.
11. Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. Cocoa and cardiovascular health. Circulation. 2009;119:1433-1441.
12. Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure. Arch Intern Med. 2007;167:626-634.
13. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. (\)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Nat Acad Sci USA. 2006;103:1024-1029.
14. McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, Coletti C, Campos H, Hollenberg NK. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol. 2006;47:S103-S109.
15. Henderson J, Joyce R. Brewing distinction: the development of cacao beverages. In: Chocolate in Mesoamerica: A Cultural History of Cacao. McNeil CL, ed. Gainesville, FL: University Press of Florida; 2006:140-153.
16. Cidell J, Alberts H. Constructing quality: the multinational histories of chocolate. Geoform. 2006;37:999-1007.
17. Zellner D, Garriga-Trillo, Rohm E, Centeno S, Parker S. Food liking and craving: across-cultural study. Appetite. 1999;33:61-70.
18. Rogers PJ, Smit HJ. Food craving and food "addiction:" a critical review of the evidence from a biopsychosocial perspective. Pharmacol Biochem Behav. 2000;66:3-14.
19. Taubert D, Berkels R, Roesen R, Klaus W. Research letters: chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA. 2003;290:1029-1030.
20. Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr. 2005;81:611-614.
21. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Bluimberg JB, Ferri C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398-405.
22. Taubert D, Roesen R, Lehmann C, Jung N, Schomig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. JAMA. 2007;298:49-60.
23. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, Blumberg JB, Ferri C. Blood pressure is reduced and insulin sensitivity increased in glucose-interolerant hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008;138:1671-1676.
24. Ried K, Frank OR, Stocks NP. Dark chocolate or tomato extract for prehyper-tension: a randomized controlled trial. BMC Comp Alternat Med. 2009;9:22.
25. Allen RR, Carson LA, Kwik-Uribe C, Evans EM, Erdman JW Jr. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J Nutr. 2008;728:725-731.
26. Fisher NDL, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxidedependent vasodilation in healthy humans. J Hypertens. 2003;21:2281-2286.
27. Engler MB, Engler MM, Chen C-Y, Malloy MJ, Browne A, Chiu EY, Kwak H-K, Milbury P, Paul SM, Bluimberg J, Mietus-Snyder ML. Flavanoid-rick dark chocolate improves endothelial function and increases plasma epi-catechin concentrations in healthy adults. J Am Coll Nutr. 2004;23:197-204.
28. Davison K, Coates AM, Buckley JD, Howe PRC. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes. 2008;32:1289-1296.
29. Muniyappa R, Hall G, Kolodzieg TL, Karne RJ, Crandon SK, Quon MJ. Cocoa consumption for 2 wk enhances insulin-mediated vasodilation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr. 2008;88:1685-1696.
30. Crews WD Jr, Harrison WD, Wright JW. A double-blind, placebo-controlled, randomized trial of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr. 2008;87:872-880.
31. Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, Heussen N, Gross HB, Keen CL, Schroeter H, Kelm M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients. J Am Coll Cardiol. 2008;51:2141-2149.
32. Scott D, Stohler C, Egnatuk C, Wang H, Keoffe R, Zubieta J-K. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron. 2007;55:325-336.
33. Pacheco-Lopez G, Engler H, Maj-Britt N, Schedlowski M. Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain Behav Immunity. 2006;20:430-446.
34. Stone D, Kerr C, Jacobson E, Conboy L, Kaptchuk T. Patient expectations in placebo-controlled randomized clinical trials. J Eval Clin Prac. 2005;11:77-84.
35. Miller KB, Stuart DA, Smith NL, Lee CY, McHale NL, Flanagan JA, Ou B, Hurst WJ. Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem. 2006;54:4062-4068.
36. McShea A, Ramiro-Puig E, Munro SB, Casadesus G, Castell M, Smith MA. Clinical benefit and preservation of flavanols in dark chocolate manufacturing. Nutr Rev. 2008;66:630-641.
37. Bortolotto LA, Henry O, Hanon O, Sikias P, Mourad JJ, Girerd X. Validation of two devices for self-measurement of blood pressure by elderly patients according to the revised British Hypertension Society protocol: the Omron HEM-722C and HEM 735C. Blood Press Monitor. 1999;4:21-25.
38. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90207 determined by to the British Hypertension Society Protocol. J Hypertens. 1991;9(suppl 5):S25-S31.
39. Beaubien ER, Card CM, Card SE, Biem HJ, Wilson TW. Accuracy of the Dinamap 1846XT automated blood pressure monitor. J Hum Hypertens. 2002;16:647-652.
40. Ottaviani JI, Actis-Goretta L, Villordo JJ, Graga CG. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Biochimie. 2006;88:359-365.
41. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem. 206;54:229-234.
42. Fraga CG. Flavonoids in heart disease and hypertension: mechanistic aspects. Presented at the International Conference on Polyphenols and Health; December 6-11, 2009; Harrogate, United Kingdom.
43. Miller KB, Hurst WJ, Flannigan N, Ou B, Lee CY, Smith N, Stu DA. Survey of commercially available chocolate-and cocoa-containing products in the United States. 2: comparison of flavnan-3-ol content with nonfat cocoa. J Agric Food Chem. 2009;57:9169-9180.
44. Ritter Sport. Dark chocolate. Available at: http://www.ritter-sport.com/ #/en-GB/product/100g-dark-chocolate. Accessed October 14, 2009.
45. Yamaguchi T, Chikama A, Mori K, Watanabe T, Shioya Y, Katsuragi Y, Tokimitsu I. Hydroxyguinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure. Nutr Metab CardiovDis. 2007;18: 408-414.
46. Suzuki A, Kagawa D, Ochiai R, Tokimitsi I, Saito I. Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res. 2007;25:99-107.
47. Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y, Saito I. The blood pressure lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens. 2006;28:439-449.
48. Suzuki A, Fujii A, Yamamoto N, Yamamoto M, Ohminami H, Kameyama A, Shibuya Y, Nishizawa Y, Tokimitsu I, Saito I. Improvement of hypertension and vascular dysfunction by hydroxyhydroquinon-free coffee in a genetic model of hypertension. FEBS Lett. 2006;580:2317-2322.
49. Nyfeler F, Moser UK, Walter P. Stereospecific effects of (+)-and (\)-catechin on glycogen metabolism in isolated rat hepatocytes. Biochim Biophys Acta. 1983;763:50-57.
50. Momma TY, Ottaviani JI, Keen CL, Springer ML, Schroeter H, Heiss C. Stereochemical properties of flavanols influence vasodilatory activity in vivo. Presented at the International Conference on Polyphenols and Health; December 6-11, 2009; Harrogate, United Kingdom
51. Fries ED. Hemodynamics of hypertension. Physiol Rev. 1960;40:27-54.
52. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol Rev. 1992;71:231-300.
53. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately: New and persistent challenges. JAMA. 2003; 289:1027-1030.
54. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280-286.
55. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354.2368-2374.